• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆红素作为一种疾病修饰剂:综合观点。

Biliverdin as a disease-modifying agent: An integrated viewpoint.

机构信息

Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Department of Healthcare Surveillance and Bioethics, Section of Pharmacology, Università Cattolica Del Sacro Cuore, Largo F. Vito, 1, 00168, Rome, Italy.

出版信息

Free Radic Biol Med. 2023 Oct;207:133-143. doi: 10.1016/j.freeradbiomed.2023.07.015. Epub 2023 Jul 15.

DOI:10.1016/j.freeradbiomed.2023.07.015
PMID:37459935
Abstract

Biliverdin is one of the three by-products of heme oxygenase (HO) activity, the others being ferrous iron and carbon monoxide. Under physiological conditions, once formed in the cell, BV is reduced to bilirubin (BR) by the biliverdin reductase (BVR). However, if BVR is inhibited by either genetic variants, as occurs in the Inuit ethnicity, or dioxin intoxication, BV accumulates in cells giving rise to a clinical syndrome known as green jaundice. Preclinical studies have demonstrated that BV not only has a direct antioxidant effect by scavenging free radicals, but also targets many signal transduction pathways, such as BVR, soluble guanylyl cyclase, and the aryl hydrocarbon receptor. Through these direct and indirect mechanisms, BV has shown beneficial roles in ischemia/reperfusion-related diseases, inflammatory diseases, graft-versus-host disease, viral infections and cancer. Unfortunately, no clinical data are available to confirm these potential therapeutic effects and the kinetics of exogenous BV in humans is unknown. These limitations have so far excluded the possibility of transforming BV from a mere by-product of heme degradation into a disease-modifying agent. A closer collaboration between basic and clinical researchers would be advantageous to overcome these issues and promote translational research on BV in free radical-induced diseases.

摘要

胆红素是血红素加氧酶 (HO) 活性的三种副产物之一,其他两种是亚铁离子和一氧化碳。在生理条件下,BV 一旦在细胞中形成,就会被胆红素还原酶 (BVR) 还原为胆红素 (BR)。然而,如果 BVR 被遗传变异(如因纽特人)或二恶英中毒抑制,BV 会在细胞中积累,导致一种称为绿色黄疸的临床综合征。临床前研究表明,BV 不仅通过清除自由基具有直接的抗氧化作用,而且还靶向许多信号转导途径,如 BVR、可溶性鸟苷酸环化酶和芳香烃受体。通过这些直接和间接的机制,BV 在与缺血/再灌注相关的疾病、炎症性疾病、移植物抗宿主病、病毒感染和癌症中显示出有益的作用。不幸的是,目前尚无临床数据证实这些潜在的治疗效果,并且人体中外源 BV 的动力学尚不清楚。这些限制迄今为止排除了将 BV 从血红素降解的副产品转变为疾病修饰剂的可能性。基础研究人员和临床研究人员之间更密切的合作将有利于克服这些问题,并促进自由基诱导疾病中 BV 的转化研究。

相似文献

1
Biliverdin as a disease-modifying agent: An integrated viewpoint.胆红素作为一种疾病修饰剂:综合观点。
Free Radic Biol Med. 2023 Oct;207:133-143. doi: 10.1016/j.freeradbiomed.2023.07.015. Epub 2023 Jul 15.
2
Human heme oxygenase-1 efficiently catabolizes heme in the absence of biliverdin reductase.人血红素加氧酶-1在缺乏胆红素还原酶的情况下能有效地代谢血红素。
Drug Metab Dispos. 2010 Nov;38(11):2060-6. doi: 10.1124/dmd.110.034777. Epub 2010 Aug 2.
3
Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin.胆红素还原酶将胆绿素转化为胆红素,有助于血红素氧合酶-1 对血管内皮细胞的保护——胆红素具有直接和间接抗氧化作用的证据。
J Mol Cell Cardiol. 2010 Aug;49(2):186-95. doi: 10.1016/j.yjmcc.2010.04.011. Epub 2010 Apr 27.
4
Heme Oxygenase-1 and Its Metabolites Carbon Monoxide and Biliverdin, but Not Iron, Exert Antiviral Activity against Porcine Circovirus Type 3.血红素加氧酶-1 及其代谢产物一氧化碳和胆红素,而非铁,对猪圆环病毒 3 发挥抗病毒活性。
Microbiol Spectr. 2023 Jun 15;11(3):e0506022. doi: 10.1128/spectrum.05060-22. Epub 2023 May 4.
5
Overview of heme degradation pathway.血红素降解途径概述。
Curr Protoc Toxicol. 2001 May;Chapter 9:Unit 9.1. doi: 10.1002/0471140856.tx0901s00.
6
Beneficial and Detrimental Roles of Heme Oxygenase-1 in the Neurovascular System.血红素加氧酶-1 在神经血管系统中的有益和有害作用。
Int J Mol Sci. 2022 Jun 24;23(13):7041. doi: 10.3390/ijms23137041.
7
Products of heme oxygenase and their potential therapeutic applications.血红素加氧酶的产物及其潜在的治疗应用。
Am J Physiol Renal Physiol. 2006 Mar;290(3):F563-71. doi: 10.1152/ajprenal.00220.2005.
8
Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase.胆红素 - 胆绿素氧化还原放大循环在胆绿素还原酶介导的细胞抗氧化保护中的作用有限。
J Biol Chem. 2009 Oct 23;284(43):29251-9. doi: 10.1074/jbc.M109.037119. Epub 2009 Aug 18.
9
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.阿尔茨海默病中血红素加氧酶/胆红素还原酶系统的两面性:和解的时候到了。
Neurobiol Dis. 2014 Feb;62:144-59. doi: 10.1016/j.nbd.2013.09.018. Epub 2013 Oct 2.
10
The heme oxygenase/biliverdin reductase pathway in drug research and development.药物研发中的血红素加氧酶/胆绿素还原酶途径
Curr Drug Metab. 2009 Jul;10(6):579-94. doi: 10.2174/138920009789375405. Epub 2009 Jul 14.

引用本文的文献

1
A Reassessment of Sarcopenia from a Redox Perspective as a Basis for Preventive and Therapeutic Interventions.从氧化还原角度对肌肉减少症进行重新评估,作为预防和治疗干预的基础。
Int J Mol Sci. 2025 Aug 12;26(16):7787. doi: 10.3390/ijms26167787.
2
Recombinant Escherichia coli biotransformation of biliverdin to synthesize bilirubin.重组大肠杆菌将胆绿素生物转化以合成胆红素。
World J Microbiol Biotechnol. 2025 Aug 26;41(9):315. doi: 10.1007/s11274-025-04527-z.
3
Causal association analysis between blood metabolomes and osteopenia and therapeutic target prediction for mechanomedicine.
血液代谢组与骨质减少之间的因果关联分析及机械医学的治疗靶点预测
Mechanobiol Med. 2025 Jun 9;3(3):100137. doi: 10.1016/j.mbm.2025.100137. eCollection 2025 Sep.
4
Metabolomic biomarkers could be molecular clocks in timing stroke onset.代谢组学生物标志物可能是中风发病时间的分子时钟。
Sci Rep. 2025 Jul 1;15(1):21645. doi: 10.1038/s41598-025-05334-0.
5
Metabolomic analysis of rat arterial serum under hypobaric hypoxia: Adaptive regulation of physiological systems by metabolic reprogramming.低压缺氧条件下大鼠动脉血清的代谢组学分析:通过代谢重编程对生理系统的适应性调节
Biochem Biophys Rep. 2025 Feb 18;41:101943. doi: 10.1016/j.bbrep.2025.101943. eCollection 2025 Mar.
6
The Heme Oxygenase/Biliverdin Reductase System and Its Genetic Variants in Physiology and Diseases.血红素加氧酶/胆绿素还原酶系统及其基因变体在生理和疾病中的作用
Antioxidants (Basel). 2025 Feb 6;14(2):187. doi: 10.3390/antiox14020187.
7
Pretreatment of Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes with Quercetin Enhances the Healing of Diabetic Skin Wounds by Modulating Host-Microbiota Interactions.用槲皮素预处理人脐带间充质干细胞衍生的外泌体可通过调节宿主-微生物群相互作用促进糖尿病皮肤伤口愈合。
Int J Nanomedicine. 2024 Nov 26;19:12557-12581. doi: 10.2147/IJN.S491471. eCollection 2024.
8
Intracellular biliverdin dynamics during ferroptosis.铁死亡过程中的细胞内胆绿素动力学
J Biochem. 2024 Dec 2;176(6):472-483. doi: 10.1093/jb/mvae067.
9
Neuroprotective Roles of the Biliverdin Reductase-A/Bilirubin Axis in the Brain.胆红素还原酶 A/B 轴在大脑中的神经保护作用。
Biomolecules. 2024 Jan 28;14(2):155. doi: 10.3390/biom14020155.